Kurma Partners
Venture capitalPre-SeedβSeries B
Investment thesis
Kurma Partners builds healthcare companies by working with leading European research institutions early in the discovery phase. The firm combines research validation with experienced healthcare industry experts and entrepreneurs to create high-tech companies, providing capital alongside specialized expertise and network support. Beyond founding new ventures, the firm supports early-stage companies already in market, having contributed to over 40 healthcare company financings.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 4 of 62 portfolio companiesBiotech Γ3Healthtech Γ2AgTech Γ1Deep Tech Γ1Digital Health Γ1EdTech Γ1Medical Devices Γ1
HQs:FranceΓ2BelgiumΓ1
Investments Β· showing 60 of 62
founders shown can be your intro pathMeiogenix develops a plant breeding technology platform that accelerates genetic gain and trait development through targeted recombination, serving crop breeders globally across specialty and field crops.
AgTechBiotech
PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally. The company operates a production facility in Belgium producing high-purity actinium-225 as an active pharmaceutical ingredient for personalized nuclear medicine treatments.
BiotechDeep TechHealthtechMedical DevicesMol, BE
Sven van den berghe(CEO)Christophe Malice(CBO)Samy Bertrand(CTO)Yves Sterckx(Director of Finance & Administration)
Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.
BiotechParis, FR
Poppins is a clinically validated digital medical device for children aged 7-11 with dyslexia and reading difficulties. The app delivers personalized 20-minute daily training sessions combining rhythm-based exercises, written language games, and visual attention activities to complement speech therapy and improve reading skills.
Digital HealthEdTechHealthtechParis, FR
Frequently asked questions
- What stage does Kurma Partners invest at?
- Kurma Partners invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does Kurma Partners focus on?
- Kurma Partners focuses on Biotech, Deep Tech, Healthtech.
- Does Kurma Partners lead rounds?
- Yes, Kurma Partners leads investment rounds.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
Octopus Ventures is a pan-European early-stage venture capital firm that invests from pre-seed through Series A and beyond, with pre-seed investments typically at Β£100k and later-stage investments starting at Β£1 million.
F Prime Capital is an investment firm composed of scientists, engineers, physicians, operators, and investors who provide real-world expertise to help portfolio companies accelerate their path to scalable growth.
Apple Tree Partners is a life sciences venture capital firm that creates and builds transformative biotechnology companies from early-stage science through public markets. The firm works with scientists at various stages, from pre-IP ideas to company spinouts, providing capital, strategic guidance, and operational resources.